# POLYSORBATE 20

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid3031949
Categories: beauty, cleaning, food, industrial, pharma
Functions: Anti-static agent, Dispersing agent, Emulsifier, Flavouring and nutrient, Fragrance, Lubricating agent, Pharmaceutical, Solubility enhancer, Surfactant (surface active agent), Thickening agent, Wetting agent (non-aqueous), anti-fogging agents
Identifier: DTXSID3031949

> POLYSORBATE 20 is used as anti-static agent / dispersing agent. EPA CPDat observed this chemical in 5362 composition records across product categories including Construction and building materials, Personal care, Laboratory supplies. Assessed from 43 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 5362 composition records across product categories including Construction and building materials, Personal care, Laboratory supplies.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 5362 composition records across product categories including Construction and building materials, Personal care, Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Emulsifier, Surfactant (surface active agent), Fragrance.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.1 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 39 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: NA
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 563 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 1.3 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 80 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 17 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 4.2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.35 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: NA
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 3.7 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CLOTH; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 108 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Potency: 2 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Potency: 5 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 2000 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO; Potency: 8 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOAP; Potency: 0.02 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 15 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: AEROSOL, FOAM; Potency: 3 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: NA
- US: inactive ingredient database — Route: VAGINAL; Dosage form: TAMPON; Potency: 64.8 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 2 drug products and 2 package presentations.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.

_Assessed by Greenveil._